Singapore markets closed

Sabra Health Care REIT, Inc. (SBRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.15-0.17 (-1.19%)
At close: 04:00PM EDT
14.27 +0.12 (+0.85%)
After hours: 07:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.28B
Enterprise value 5.71B
Trailing P/E 67.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.06
Price/book (mrq)1.18
Enterprise value/revenue 8.75
Enterprise value/EBITDA 16.93

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 334.63%
S&P500 52-week change 325.26%
52-week high 314.92
52-week low 310.30
50-day moving average 314.23
200-day moving average 313.85

Share statistics

Avg vol (3-month) 31.95M
Avg vol (10-day) 31.69M
Shares outstanding 5231.5M
Implied shares outstanding 6231.5M
Float 8229.05M
% held by insiders 11.14%
% held by institutions 196.20%
Shares short (30 Apr 2024) 412.95M
Short ratio (30 Apr 2024) 46.93
Short % of float (30 Apr 2024) 48.07%
Short % of shares outstanding (30 Apr 2024) 45.60%
Shares short (prior month 28 Mar 2024) 411.19M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 48.48%
Trailing annual dividend rate 31.20
Trailing annual dividend yield 38.38%
5-year average dividend yield 49.05
Payout ratio 4571.43%
Dividend date 331 May 2024
Ex-dividend date 417 May 2024
Last split factor 21:3
Last split date 316 Nov 2010

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 7.61%
Operating margin (ttm)34.60%

Management effectiveness

Return on assets (ttm)2.59%
Return on equity (ttm)1.72%

Income statement

Revenue (ttm)650.28M
Revenue per share (ttm)2.81
Quarterly revenue growth (yoy)3.50%
Gross profit (ttm)N/A
EBITDA 393.91M
Net income avi to common (ttm)49.5M
Diluted EPS (ttm)0.21
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)87.06M
Total cash per share (mrq)0.38
Total debt (mrq)2.48B
Total debt/equity (mrq)89.47%
Current ratio (mrq)1.33
Book value per share (mrq)11.95

Cash flow statement

Operating cash flow (ttm)285.08M
Levered free cash flow (ttm)197.14M